DATATRAK International, Inc. (DATA: OTC Link) | DATATRAK Selected as 2012 Crain’s Leading EDGE Honoree

DATATRAK Selected as 2012 Crain’s Leading EDGE Honoree

May 21, 2012

OTC Disclosure News Service

Mayfield Heights, OH –

CLEVELAND, May21 /PRNewswire/ — DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the Company’s selection as a 2012 Crain’s Leading EDGE award winner; this is DATATRAK’s third consecutive year to be honored.

“This award is gratifying; to be recognized as a company that creates value for itself as well as its community solidifies that we are on the path to achieving our vision,” stated Laurence P. Birch, DATATRAK’s Chairman of the Board and CEO. “Leading EDGE appreciates the growth of our comprehensive cloud-based global clinical research platform, DATATRAK ONE™, and the difference it is making in the marketplace as it safely accelerates products to market.”

About Crain’s Leading EDGE Awards

The Entrepreneurs EDGE is a resource for CEOs and their Leadership Teams to share best practices, help solve challenging issues, and take best advantage of their biggest opportunities.  EDGE is a 501 (c) (3) non-profit founded in 2005 to enhance economic development in Northeast Ohio. Please see http://www.edgef.org for additional information.

About DATATRAK

DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK’s Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management’s expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company’s quarterly report filed with the OTCQX Market on May 10, 2012 announcing its results for the three-month period ending March 31, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

CONTACT:

Lisa Pahl, Director Marketing, DATATRAK International, Inc., +1-979-393-9025

 

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Article source: http://www.otcmarkets.com/stock/DATA/news?id=47870

Leave a Reply

WP2FB Auto Publish Powered By : XYZScripts.com
Bunk Beds